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Feasibility of Gastric Cancer Surgery 
at Low Volume Hospitals
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Department of Surgery, The Catholic University of Korea, School of Medicine, Seoul, Korea
Purpose: Most gastric cancer patients undergo operations at large tertiary hospitals in Korea. However, some patients are treated at low 
volume hospitals. We investigated patient outcomes after gastric surgery at a secondary hospital and compared with outcomes of large 
volume centers.
Materials and Methods: We included 184 patients who underwent gastric surgery for gastric cancer at our hospital from January 2003 
to December 2008. We conducted a retrospective study and evaluated the clinicopathological characteristics, clinical outcomes and sur-
vival rate of patients.
Results: Mean age was 61.7 years old. Male to female ratio was 2.2 : 1. Proportion of early gastric cancer was 38.6% and that of 
advanced gastric cancer was 61.4%. The 5 year overall survival rate of 184 patients was 66.3%. The overall survival rate was signifi-
cantly lower for people over 62 years old. The morbidity rate and mortality at our hospital were 10.3% and 0.5%, respectively.
Conclusions: The overall survival rate, morbidity and mortality were similar to those of the previous reports from Korea. Treatment of 
gastric cancer at a secondary hospital is feasible and safe. Standardization of operations and management of gastric cancer patients of 
the Korean Gastric Cancer Association is the most important factor to achieve these outcomes.
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Introduction
Gastric cancer is still the second leading cause of cancer death 
worldwide.(1) Although the incidence is on the decrease in Korea, 
according to the annual report of cancer incidence (2007), cancer 
prevalence (2007) and survival (1993~2007) in Korea, in 2007, 
25,915 new cases were developed. At 16% of cancers developed 
during that time, gastric cancer has the highest incidence. It appears 
to be reduced substantially in comparison with 20.2% in 2002. 
Nonetheless, 2,700 cases developed in one year. In 2007, 20.3% of 
male cancers was gastric cancer, which makes it the most frequent.  
In females gastric cancer was 11.2% of female cancers, which 
makes it the third most frequent cancer.  Thus it is one of the most 
important cancers in Korea.(2) Since surgical resection is the only 
treatment that can improve survival rates in gastric cancer, success-
ful surgeries are essential. 
Gastric cancer occurs evenly in all geographical areas in Korea. 
Nonetheless, most patients are treated at large-volume centers in 
the capital.(3) The outcome of surgeries compared to the number 
of surgeries performed is of paramount importance to patients and 
their families. Nevertheless, the size of the hospital and the number 
of surgery cases performed cannot reflect all technical aspects of 
treatments for cancer patients. Therefore, we examined the clini-
copathological characteristics of patients who underwent surgery 
for gastric cancer at medium-sized hospitals (about 400 beds) in 
comparison with large hospitals. Post-surgical morbidity, mortality, 
and long-term survival rate were examined, and compared with 
the published treatment outcomes of surgery in large hospitals.Gastric Cancer Surgery at Low Volume Hospitals
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Materials and Methods
The subjects were all patients who were diagnosed with gastric 
cancer and received surgery in the Department of Surgery, The 
Catholic University of Korea, School of Medicine, Saint Paul’s Hos-
pital from January 2003 to December 2008. There were 184 patients 
in total, and their medical records were examined retrospectively. 
The age of the patient, gender, symptoms, and symptomatic pe-
riod were examined. As clinicopathological factors, the location of 
gastric cancer, macroscopical classification, histopathological clas-
sification, and Lauren’s classification were applied. For the TNM 
disease stage classification, the guidelines of the Union for Inter-
national Cancer Control (UICC), 6th edition, were used to be able 
to compare these records with other studies. The surgical methods, 
reconstruction methods, the number of resected lymph nodes, 
postoperative complications and survival rate were examined, since 
they are the outcomes pertinent to surgery. In the examination 
of postoperative complications, wound seromas were included in 
wound infection. Hemorrhage was defined as bleeding in drain-
age tubes or the nasogastric tube, vital signs were changed, or 
postoperative hemoglobin value was reduced by more than 3 g/dl. 
Intestinal obstruction was defined as abdominal pain or vomiting, 
and the ileus was detected by plain abdominal imaging. Pulmonary 
complications were defined as fever and diagnosed by plain radio-
logical images. The leakage from anastomosis and intra-abdominal 
abscesses were diagnosed by clinical symptoms such as abdominal 
pain and fever and abdominal computed tomography. Postopera-
tive death was defined as death within 30 days after surgery during 
hospitalization. In cases where radical resection was performed, 
stages were assessed. For cases with serosal infiltration or with 
lymph node metastasis, considering the condition of the patient, 
chemotherapy based on 5-FU was performed after surgery. For 
inoperable cases, palliative chemotherapy was performed. Surgeries 
were performed by surgeons with more than 20 years experience 
and 2 surgeons with experience in more than 100 cases. Except in 
cases with distant metastasis or inoperable tumors in which pallia-
tive surgery was performed, a lymphadenectomy higher than D2 
was the standard surgery. For early gastric cancer, a lymphadenec-
tomy higher than D1+β was performed. The record of surgery and 
the record of the information of patients were prepared using the 
common form of the Department of Surgery, The Catholic Uni-
versity of Korea, School of Medicine prepared following the form 
of the Korean Gastric Cancer Association. For the management of 
patients after surgery, the common critical pathway of the Depart-
ment of the Upper Gastrointestinal tract by The Catholic University 
of Korea, School of Medicine was applied.(4) At our hospital, the 
ambulatory follow-up observation was performed at a 3 month 
interval for 3 years after surgery, and subsequently at a 6 month 
interval for the next 5 years. Tumor marker checks and abdominal 
computed tomography were performed at a 3 month interval and 
esophagogastroscopic examination was performed at a 6 month in-
terval. Based on the data, the medical records of patients who vis-
ited our outpatient department or were hospitalized between April 
2010 and July 2010 were analyzed, patients responded to follow-
up telephone interviews. All results were analyzed retrospectively 
based on medical records. The research protocols were approved 
by the IRB of our institute (IRB No.: PC10RISI0036). 
In our study, statistical analysis was performed using the SPSS 
ver. 12.0 statistics program for Windows (SPSS Inc., Chicago, IL, 
Table 1. Characteristics of stomach cancer patients and surgery
No. of patients (N=184) %
Sex
    Male 126 68.5
    Female 58 31.5
Age (year)
    Mean±SD 61.7±10.8
Symptoms
    None 54 29.3
  Non-complicated symptoms 116 63.1
  Complications
    Perforation 4 2.2
    Bleeding 10 5.4
Duration of symptoms
    <1 month 62 47.7
    1~12 months 65 50
    >1 years 3 2.3
Operation title
    Total gastrectomy 29 15.8
    Distal gastrectomy 131 71.2
    Proximal gastrectomy 5 2.7
    Bypass operation 3 1.6
    Expoloratory laparotomy 16 8.7
Operation time (min) 
    Mean±SD 200.9±73.1 (9~365)
Total extracted lymph nodes
    Mean±SD 33.1±17.4  
SD = standard deviation.Kim MR, et al.
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USA). the survival rate was obtained by the Kaplan-Meier method. 
Statistical significance between survival curves was validated by a 
log rank test, and a P-value less than 0.05 was considered to be 
significant. 
Results
184 patients received surgery for gastric cancer at our hospital 
from January 2003 to February 2008. They were all enrolled in this 
study.
1. Gender and age
Among the total patients, 126 cases were male (68.5%) and 58 
cases were female (31.5%). The ratio of male to female was 2.2 : 1. 
The mean age was 61.7 years (Table 1).
2. Symptoms
Pain and discomfort of the upper abdomen was most prevalent 
in 100 cases (54.3%).  Asymptomatic cases (29.3%) were next, fol-
lowed by hemorrhage (5.4%). In symptomatic cases, the symptom-
atic period of less than 6 months was 110 patients, and it accounted 
for approximately 85% of patients (Table 1).
3. The location of tumors and macroscopic classifi-
cation
In 24 cases (13%), the tumor was located in the upper area of 
the stomach. In 36 cases (19.6%) it was in the middle area, and in 
119 cases (64.7%) it was the lower area. In five cases the tumor had 
invaded the entire stomach (Table 2). In the macroscopic classifica-
tion, 71 cases (38.6%) had early gastric cancer 61.4% of cases had 
advanced gastric cancer. Among early gastric cancer cases, type IIc 
was 62%, which was the most prevalent. Type III was 2.8%, which 
was the least frequent. In advanced gastric cancer cases, Borrmann 
type 1 was 3 cases (2.7%), which was least frequent. Type 3 was 86 
cases (76.1%), which was most prevalent. 
4. The results and surgical methods
There were 29 total gastrectomies, 131 distal gastrectomies, and 
5 proximal gastrectomies. Gastroduodenostomy was performed in 
96 cases (73.3% of the entire cases. Gastrojejunostomy was per-
formed in 35 cases (26.7%). Two cases were inoperable and thus 
palliative resection was performed. In resection cases, the operation 
time was an average of 201 minutes, with a maximum of 365 min-
utes and a minimum of 95 minutes. 19 cases were unable to have 
a resection, 3 cases were terminated by bypass, and 16 cases were 
terminated by diagnostic laparatomy. There were on average  33.1 
resected lymph nodes (±17.4). The post-surgical hospitalization 
period was 12.3 days (Table 1). 
5. Histological results of tumors
In the T classification, 71 cases (38.6%) were T1, 62 cases (33.7%) 
were T2, 28 cases (15.2%) were T3, 4 cases (2.2%) were T4 and 
19 cases (10.3%) were unknown. In the N classification, 91 cases 
(49.5%) were N0, 45 cases (24.5%) were N1, 12 cases (6.5%) were 
N2, 15 cases (8.5%) were N3, and 21 cases (11.4%) were unknown. 
In the M classification, 163 cases (88.6%) were M0, and 21 cases 
Table 2. Five-year survival rate according to clinicopathologic 
features
No. of 
patient
5-ysr 
(%)
P-value
Age 0.015
    ≤62 82 75.6
    >62 102 58.8
UICC TNM stage <0.001
    Ia 67 94.0 
    Ib 22 90.1 
    II 32 75.0 
    IIIa 14 35.7 
    IIIb 5 20.0 
    IV 44 20.5 
Lauren classfi  cation <0.001
    Intestinal 60 81.6
    Diff  use 35 65.1
    Mixed 34 65.0 
Lymphatic invasion <0.001
    Negative 84 90.5
    Positive 81 54.3
    Unknown 19
Venous invasion <0.001
    Negative 135 79.3
    Positive 30 43.3
    Unknown 19
Neural invasion <0.001
    Negative 61 85.3
    Positive 23 73.9
    Unknown 100
UICC = Union for International Cancer Control.Gastric Cancer Surgery at Low Volume Hospitals
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(11.4%) were M1. In regard to the disease stage, 67 cases (36.4%) 
were stage Ia, 22 cases (12.0%) were stage Ib, 32 cases (17.4%) were 
stage II, 14 cases (7.6%) were stage IIIa, 5 cases (2.7%) were stage 
IIIb, and 44 cases (23.9%) were stage IV (Table 3).
6. Early complications after surgery and mortality
Among the 184 cases, 19 cases developed complications (10.3%). 
Among them, 6 cases were wound complications, 2 cases were 
hemorrhage, 3 cases were intestinal obstruction, 2 cases were anas-
tomosis leakage, and 3 cases were respiratory complications. Pa-
tients with second operations did so for one case of hemorrhaging, 
one case of anastomosis leakage, and the remaining patients were 
improved by symptomatic treatments. One patient died of sepsis 
following an intra-peritoneal abscess due to duodenal stump leak-
age after a distal gastrectomy, making the mortality rate 0.5%.
7. Postsurgical adjuvant? chemotherapy
Among all patients, 82 patients (45.3%) received adjuvant che-
motherapy after radical resection. For the 21 patients who could 
not get a radical resection, palliative chemotherapy was performed 
(11.6%). 81 patients (44%) did not receive chemotherapy. 
8. 5-year survival rate
All 184 patients were able to be followed up on without any 
dropouts in the middle of the study. The average follow-up pe-
riod was 4.3 years (±25.3 months, minimal 1 month, maximal 90 
months). The 5-year survival rate of all patients who underwent 
surgery was 66.3%. The 5-year survival rate broken down by dis-
ease stages looks like this: stage Ia was 94.0%, Ib was 90.1%, II 
was 75.0%, IIIa was 35.7%, IIIb was 20.0%, and IV was shown to 
Table 3. Continued
No. of cases
(N=184)
%
Lymphatic invasion
    Negative 84 45.7
    Positive 81 44
    Unknown 19 10.3
Venous invasion
    Negative 135 73.4
    Positive 30 16.3
    Unknown 19 10.3
Neural invasion
    Negative 61 33.2
    Positive 23 12.5
    Unknown 100 54.3
UICC = Union for International Cancer Control.
Table 3. Characteristics of tumors 
No. of cases
(N=184)
%
Location of tumor
    Upper third 24 13
    Middle third 36 19.6
    Lower third 119 64.7
    Whole stomach 5 2.7
Gross type  
    Early gastric cancer 71 38.6
    Advanced gastric cancer 113 61.4
Histology  
    Diff  erentiated 88 47.8
    Undiff  erentiated 82 44.6
    Other 14 7.6
Lauren classifi  cation
    Intestinal 60 46.5
    Diff  use 35 27.1
    Mixed 34 26.4
Depth of invasion
    T1 71 38.6
    T2 62 33.7
    T3 28 15.2
    T4 2 2.2
    Unknown 19 10.3
Lymph node metastasis
    N0 91 49.5
    N1 45 24.5
    N2 12 6.5
    N3 15 8.2
    Unknown 21 11.4
Distant metastasis
    M0 163 88.6
    M1 21 11.4
UICC TNM stage
    Ia 67 36.4
    Ib 22 12
    II 32 17.4
    IIIa 14 7.6
    IIIb 5 2.7
    IV 44 23.9Kim MR, et al.
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be 20.5% (Fig. 1). Based on the mean age of 62 years, the survival 
rate of the group younger than 62 years was 75.6% and the group 
older than 62 years was 58.8%, which was significantly different 
(P=0.015). In Log lank test, P-value was 0.001, and thus in univar-
iate analysis, it was significant. However, the number of all patients 
was small, and particularly stage IIIb was only 5 cases. Thus it was 
too small to assess statistical significance (Table 3). Among the 163 
patients who experienced radical resection, 18 patients (11%) had 
confirmed recurrence. The recurrence area was in the order of the 
peritoneum (9 patients), lymph nodes (6 patients), lung (2 patients), 
colon (2 patients), liver (2 patients), anastomosis area (2 patients), 
and ovary (2 patients). Among them, 5 patients had cancer recur in 
more than 2 sites. For one case recurred in the anastomosis area, 
radical resection was usable and was performed. The remaining 
cases were treated with second chemotherapy without surgery. 
Discussion
In Korea, particularly surgery for gastric cancer patients, the 
tendency is to receive operation at large tertiary hospitals in the 
capital area. The phenomenon becomes more serious as large hos-
pitals built cancer centers. However, in reality, more than 60% of all 
patients are treated at small-sized hospitals. Nevertheless, in gastric 
cancer patients, studies on the association of the number of surgery 
cases with surgery outcomes and prognosis are not abundant. 
Reviewing the studies showed that the number of surgeries exert 
effects on post-surgical mortality. Finlayson et al.(5) report in a 
study conducted on patients treated at veterans hospitals that the 
mortality of large volume centers was 6.9%, middle volume centers 
was 7.4%, and low volume centers was 8.7%. Although differences 
were shown, it was not statistically significant. In a study conducted 
in Sweden, Hansson et al.(6) report that comparing the mortality at 
2 months after surgery, the mortality at hospitals corresponding to 
university hospitals performing a large number of operations was 
lower than the mortality at local hospitals. Smith et al.(1) report 
that the data of the entire US was examined, and it was found 
that post-surgical mortality was lower in the hospital group with a 
large number of annual surgery cases. In contrast, it has been also 
reported that the number of surgery cases was not associated with 
post-surgical mortality. Damhuis et al.(7) examine the data of the 
Rotterdam cancer registration center, and report that post-surgical 
mortality was not associated with the number of surgeries per-
formed. In addition, Reavis et al.(8) report that hospitals performing 
more than 13 surgeries annually were classified as the large volume 
group, hospitals performing between 6 and 12 cases as the medium 
volume group, and hospitals performing less than 5 cases as the low 
volume group, out of 121 hospitals total and 2,169 cases examined. 
Postoperative complications, re-hospitalization rates and mortality 
were compared. Differences among the groups were not observed. 
Reviewing studies conducted in Korea on gastric cancer patients 
regarding the mortality and morbidity after surgery, Park et al.(9) 
report that in 719 patients, it was 17.4% and 0.6%, respectively. Cho 
et al.(10) report that in 1,028 patients, it was 5.9% and 0.1%, re-
spectively. Kim et al.(3) report that in 201 patients, it was 10.4% and 
0.5%, respectively. In the results of our study, after gastric resection, 
complications were developed in 19 cases (10.3%), and there was 
one death by sepsis. However, since the definition of complications 
after surgery is vague sometimes, it may be influenced by associ-
ated diseases and many other factors, and in retrospective studies 
it is unavoidably affected by the presence or absence or records. 
Therefore, Lee and Yang(11) report that it is required to standardize 
the definition of complications after a gastrectomy, recoding forms 
and treatment protocols.
Some studies examine the association of the number of surger-
ies for gastric cancer performed in a hospital and the post-surgical 
long-term survival rate, Nomura et al.(12) examine the relationship 
of 5-year survival rate with the number of surgeries performed at 
a hospital by analyzing the database registered at the Osaka can-
cer registration center. When the surgeries performed by hospitals 
from 1975 to 1979 were divided into 4 groups from hospitals per-
forming many surgeries to hospitals performing few surgeries and 
compared, it was observed that the odds ratio of the long-term 
survival rate of patients was significantly different. However, when 
the difference during the 5 years from 1990 to 1994 of the three 
groups excluding hospitals performing the least number of surger-
Fig. 1. Kaplan-Meier survival curves according to tumor stages.Gastric Cancer Surgery at Low Volume Hospitals
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ies was examined, the differences disappeared. The authors said 
that it might be due to the standardization of surgery and advanced 
surgical techniques were applied even in small-sized hospitals. 
In a study conducted in Germany, the 5-year survival rate of the 
hospital group performing more than 20 cases of surgery annually 
was 10.6%, which was significantly higher than 3.4% of hospitals 
performing 1~4 cases of surgery annually.(13) Reviewing the above 
studies, it appears that the long-term survival rate of large-volume 
centers is advantageous. Nevertheless, studies performed in western 
countries have limitations because they were studies conducted in 
areas where the incidence of gastric cancer is low, and the standard 
cases of a large volume center is no more than 10~20 cases per 
year. Thus it is not appropriate to apply directly to Korean cases. 
Even in studies conducted in Japan where the incidence is as high 
as Korea, the minimum surgery group showing differences was 
less than 20 cases annually, and differences were not detected in 
the group performed more than 20 cases of gastrectomy surgery 
annually.(12) In another study conducted in Korea, the long-term 
survival rate of stage Ia was 92.7%, stage Ib was 89.1%, stage II 
was 82.4%, stage IIIa was 67.5%, stage IIIb was 41.4%, stage IV 
was 24.2%, and the overall 5-year survival rate was reported to be 
69.6%.(14) In another study examining the overall 5-year survival 
rate, Noh et al.(15) reports 65%, and Park et al.(16) reports 66.8%. 
In our study, the 5-year survival rate of all patients after surgery 
for gastric cancer was 66.3%, which was not greatly different from 
other recent reports. The 5-year survival rate according to disease 
stage was that stage Ia was 94.0%, stage Ib was 90.1%, stage II was 
75.0%, stage IIIa was 35.7%, stage IIIb was 20.0%, and stage IV was 
shown to be 20.5% (Fig. 1). 
In the result of our study, the distribution of patients by stage 
was that stage Ia was 36.4%, stage Ib was 12.0%, stage II was 17.4%, 
stage IIIa was 7.6%, stage IIIb was 2.7%, and stage IV was 23.9%. 
Comparing the result with the report of the 2004 nationwide gastric 
cancer report in Korea, hospitals performing less than 100 cases 
annually, which was group 1, and in this group stage Ia was 39.3%, 
stage Ib was 13.0%, stage II was 12.4%, stage IIIa was 9.7%, stage 
IIIb was 4.9%, and stage IV was 20.2%. Hospitals performing more 
than 500 cases of surgery annually and thus classified as group 4 
had similar values, since stage Ia was 41.0%, stage Ib was 16.0%, 
stage II was 13.8%, stage IIIa was 10.1%, stage IIIb was 4.3%, and 
stage IV was 14.6%. Although the tendency was that stage IV was 
slightly more abundant at our study, differences were not detected. 
An average of 33 lymph nodes were resected during surgery, which 
was not different from the result of the report average 34 lymph 
nodes.(17) Nonetheless, in regard to pathological findings, the re-
cord of lymph node invasion and perineural invasion was omitted 
in many cases. This is due to the absence of pathologists in charge 
of only gastric cancer because of the size of the hospital. 
Our hospital performs approximately 30~40 gastrectomies for 
gastric cancer annually, and the number of operations are smaller 
than large hospitals. Nevertheless, surgeons specializing in gas-
tric cancer perform surgery and manage surgery almost from the 
beginning to the end because the absolute number of residents is 
small, the level of participation in surgery is high, and it is thought 
that the care of patients prior to and after surgery should be more 
comprehensive. For the management of the admission of patients 
for surgery, the standardized critical pathway of the division of gas-
trointestinal surgery, Department of General Surgery, The Catholic 
University of Korea, School of Medicine has been applied, and pa-
tients are managed by the identical gastric cancer record form, and 
thus it is considered that the quality of the management of patients 
is not different from large centers.(4) In addition, since the number 
of cases is not large, it has an advantage that the surgeons in charge 
could directly conduct and manage telephone interviews.   
In Korea, after the establishment of the Korean Gastric Cancer 
Association, efforts have been made to prepare comprehensive 
medical records for the standardization of surgery and the man-
agement of the data of gastric cancer patients.(18) Consequently, 
surgical outcomes have been improved continuously, and similar 
results were obtained from most hospitals. Nonetheless, in Korea, 
there was no report that the post-operative outcomes for gastric 
cancer performed after the classification of hospitals according to 
the number of gastric cancer surgeries as well as long-term survival 
rates.
This study has limitations in that it may contain errors of ret-
rospective studies, the number of total patients was small, and the 
follow-up period was not sufficient. In addition, this study is not 
based on the one to one comparison with the data of large volume 
centers but based on the comparison of the literature. Moreover, 
sufficient data and standard for large hospitals were not secured. 
However, starting with this, if data management practices improve 
to the level of Japan or other countries so that the overall data 
management is more standardized and the content of the current 
data management by Korean Central Cancer Registry becomes 
more comprehensive, more objective indexes could be provided. 
Furthermore, surgical treatments for gastric cancer performed by 
each hospital could be evaluated objectively.
Although surgery for gastric cancer patients is performed at Kim MR, et al.
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large hospitals in the capital area in many cases, a large number of 
surgeries are performed in small sized hospitals where numerous 
surgeons make efforts to treat gastric cancer patients. Our hospital 
is one such hospital, and the mortality and morbidity after surgery 
were not greatly different from large hospitals. This is thought to 
be due to the continuous standardization of surgery and the ap-
plication of systemic lymphadenectomy as well as the compliance 
of the standardization of the Korean Gastric Cancer Association for 
the management of patients after surgery, the application of post-
surgical adjuvant chemotherapy and the follow-up observation. 
The number of gastric cancer patients was small in the secondary 
hospitals, so the follow-up could be performed on all 184 subject 
patients without dropouts, and thus secondary hospitals have ad-
vantages such as thorough management of patients. Here, of course, 
the prerequisite is the presence of clinicians specifically studying 
gastric cancer. Ultimately, for better treatment outcomes of all 
gastric patients, the standardization of treatments for gastric cancer 
should be continued, and furthermore, efforts should be made to 
achieve the improvement of treatments equally.
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